Database analysis of 22 ALL cell lines in the DepMap portal did not show any difference in PRIMA-1 sensitivity depending on TP53 status (Fig. 3C) as has also been observed in a Pan-Cancer setting and overall in tumors of hematological lineages [42]. The gene discussed is TP53; the disease is acute lymphoblastic leukemia.